OPKO buys Claro Diagnostics

Brian Dunham | | Health Imaging | Enterprise Imaging
Miami-based OPKO Health has acquired Woburn, Mass.-based Claro Diagnostics, a developer of a method to use microfluidics to perform up to 20 tests with a drop of blood.

The system consists of a disposable test cassette and a small desktop analyzer. Used together, the two perform blood tests and permit the transition of complex immunoassays to physicians’ offices, according to a release. The equipment can also be used for urology and infectious disease market applications, according to the company.

Financial details of the transaction were not disclosed.

Brian Dunham

Related Content

Less than half of incidental interstitial lung abnormalities on CT exams are reported
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Rads are more accurate when they have access to patients' self-reported symptoms
AI-based software improves follow-up imaging adherence by 74%

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.